Medical engineering in Germany is a stable sector with high growth and employment rates as well as a high export share, and functions as a driver of innovation for the whole healthcare sector. Due to its innovative products, Germany has a pioneer role in the international comparison. In order to ensure that this continues in the future, and that healthcare provision for the population can be maintained at a high level under the given societal challenges of demographic change, products with new perspectives for personalized medicine will have to be developed and produced highly dynamically, in very short development cycles or even "on demand". This can only be achieved by a translational, interdisciplinary and more efficient research and development which is perfectly tailored to the customer's needs.
The business area of Medical Engineering of the Fraunhofer IBMT supports clients with its inter-departmental translational overall concept being unique in the Fraunhofer-Gesellschaft based on infrastructure, as well as excellent personnel and highly developed networks with over 30 years of experience in biomedical engineering.
To ensure easy and rapid market entry for our clients, regulatory aspects are considered in all project phases, and quality and risk management issues relevant for certification including documentation accompanies the project from start to finish. This ranges from cellular basic experiment by GMP-certified laboratories, through development-accompanying quality assurance according to MDD 93/42 EEC, over the licensing process for medical products including clinical studies, right up to certified production (ISO 9001/13485) and manufacturing development including customer-specific employee training and subsequent transfer to production.
The business area of Medical Engineering offers stakeholders a unique competence and technology portfolio: the development of hardware and software for medical products, systems for molecular diagnostics and therapy, microsystems, biohybrid and tissue engineering systems, optical, scalable acoustic and opto-acoustic imaging techniques and measurement systems, sensor manufacturing technologies, neuroprosthetic electrodes and systems, active implants, multilocal sensors, biotelemetry and wireless energy supply, right up to complete health information systems and medical networks for professional use or for end users. On this basis, and with the flexible structure of interdisciplinary project teams, customer-specific problems can be newly approached from many different perspectives. Ideas can be evaluated rapidly and solutions can be offered on a time and cost-efficient basis.
Fraunhofer IBMT is the "Hub for medical engineering in Germany" with excellent networking within the Fraunhofer-Gesellschaft and external staff members being recognized experts in scientific organizations, at standardization bodies and user organizations, as well as actively lived cooperations with said bodies, authorities, clinicians and satisfied customers.
© Photo Fraunhofer IBMT, Bernd Müller.
Ultrasound allows non-invasive and real-time imaging with resolutions down to the sub-millimetre range. Non-invasiveness, freedom from ionising radiation and relatively low procurement and operating costs and scalability makes ultrasound the most-used diagnostic imaging method worldwide.